Prostate cancer vaccine (Advaxis)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameProstate cancer vaccine (Advaxis)
Drug Alias NameLive attenuated Listeria-based vaccines for cancer ,Lovaxin P前列腺癌疫苗 - AdvaxisADXS-31142ADXS-PSA
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsAnti-PSA
TargetsProstate-specific antigen
Therapy Area/IndicationsProstatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAyala Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAyala Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A